메뉴 건너뛰기




Volumn 12, Issue 1, 2000, Pages 30-35

Clinical studies of new "biologic" approaches to therapy of acute myeloid leukemia with monoclonal antibodies and immunoconjugates

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY CONJUGATE; BISMUTH; CD33 ANTIBODY; CD33 ANTIBODY I 131; CD33 ANTIGEN; CD45 ANTIBODY; CD45 ANTIBODY I 131; CD45 ANTIGEN; CYCLOPHOSPHAMIDE; CYTARABINE; CYTOTOXIC AGENT; GEMTUZUMAB OZOGAMICIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR ANTIBODY; HYBRID PROTEIN; IDARUBICIN; IMMUNOTOXIN; IODINE 131; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY HUM 195; MONOCLONAL ANTIBODY HUM 195 BI 213; RADIOISOTOPE; RETINOIC ACID; UNCLASSIFIED DRUG;

EID: 0034519298     PISSN: 10408746     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001622-200001000-00005     Document Type: Review
Times cited : (21)

References (25)
  • 11
    • 0024602797 scopus 로고
    • Precursors of colony-forming cells in humans can be distinguished from colony-forming cells by expression of the CD33 and CD34 antigens and light scatter properties
    • (1989) J Exp Med , vol.169 , pp. 1721-1731
    • Andrews, R.G.1    Singer, J.W.2    Bernstein, I.D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.